MIAMI--(BUSINESS WIRE)--OrganaBio, LLC (“OrganaBio”), a provider of MSCs, HSCs, and immune cells for cell and gene therapy developers, has begun construction on its current Good Manufacturing ...
Nes Ziona, Israel, July 12, 2021 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the "Company"), a clinical-stage macrophage reprogramming immunotherapy company, today announced that it ...
(MENAFN- GlobeNewsWire - Nasdaq) Nes Ziona, Israel, July 12, 2021 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the“Company”), a clinical-stage macrophage reprogramming immunotherapy ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果